CN107050282A - A kind of Chinese medicine preparation for being used to treat cholecystitis - Google Patents
A kind of Chinese medicine preparation for being used to treat cholecystitis Download PDFInfo
- Publication number
- CN107050282A CN107050282A CN201710255336.6A CN201710255336A CN107050282A CN 107050282 A CN107050282 A CN 107050282A CN 201710255336 A CN201710255336 A CN 201710255336A CN 107050282 A CN107050282 A CN 107050282A
- Authority
- CN
- China
- Prior art keywords
- parts
- cholecystitis
- chinese medicine
- medicine preparation
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
Abstract
The invention belongs to technical field of traditional Chinese medicines, and in particular to a kind of Chinese medicine preparation for being used to treat cholecystitis.This is used for the Chinese medicine preparation for treating cholecystitis, is prepared from using Chinese medicines such as potentilla chinensis, leatherleaf mahonia, Cortex hibisus syriacus, lily, honeysuckle, oriental wormwood, rheum officinale, phoenix-tail fern, lilac daphnes.Its advantage is：Easy to use, each medicine supplements and complements each other, and has significant curative effect for cholecystitis, and without obvious toxic-side effects, cure rate is high, and safe and reliable, short treating period, curative effect is fast, and effect is good.
Description
Technical field
The invention belongs to technical field of traditional Chinese medicines, and in particular to a kind of Chinese medicine preparation for being used to treat cholecystitis.
Background technology
Chronic cholecystitis is clinically common disease, frequently-occurring disease, often because of acute cholecystitis treatment not thoroughly or cholecystolithiasis
Or feelings will is unsuccessful, the factor such as eating and drinking without temperance causes recurrent exerbation, touching refractory.Treatment chronic cholecystitis commonly used single west in the past
Medical service law, western medical treatment is based on anti-inflammatory, cholagogic, spasmolysis, analgesic, but effect is not satisfactory, by the long-term practice of inventor
Draw, Chinese medicine, which controls chronic cholecystitis, has preferable effect, obtains good effect.
The content of the invention
Defect of the present invention in order to make up prior art treats notable there is provided one kind is safe and reliable, easy to use, keeps away
Exempt from the Chinese medicine preparation for being used to treat cholecystitis of generation drug dependence.
The Chinese medicine preparation for being used to treat cholecystitis of the present invention, its raw material is constituted in mass ratio：9-15 parts of potentilla chinensis；
12-18 parts of leatherleaf mahonia；3-9 parts of Cortex hibisus syriacus；6-15 parts of lily；6-15 parts of honeysuckle；6-15 parts of oriental wormwood；9-30 parts of rheum officinale；Phoenix tail
It is careless 15-60 parts；1-3 parts of lilac daphne.
The medicine effect of each medicine composition：
Potentilla chinensis：【Meridian distribution of property and flavor】It is cold in nature, bitter.Return large intestine channel, lung channel, Liver Channel.
【Effect and effect】Clearing heat and detoxicating, cooling blood and hemostasis.Belong to the heat-clearing and detoxifying drug of antipyretic subordinate classification.
Leatherleaf mahonia：【Meridian distribution of property and flavor】It is cold in nature, bitter.Return liver warp, stomach, large intestine channel.
【Effect and effect】Heat-clearing and damp-drying drug, purging intense heat and detonicating.Belong to the heat-clearing and damp-drying drug of antipyretic subordinate classification.
Cortex hibisus syriacus：【Meridian distribution of property and flavor】Cold nature, sweet, hardship.Return large intestine channel, Liver Channel, the spleen channel.
【Effect and effect】Clearing heat and promoting diuresis, desinsection is antipruritic.Belong to desinsection antipruritic.
Lily：【Meridian distribution of property and flavor】It is cold in nature, it is sweet.Thoughts of returning home warp, lung channel.
【Effect and effect】Yin nourishing and lung moistening, clearing away the heart fire and tranquillizing.The yin tonics classified under category qi-restoratives medicine.
Honeysuckle：【Meridian distribution of property and flavor】It is cold in nature, it is sweet.Return lung warp, the heart channel of Hang-Shaoyin, stomach.
【Effect and effect】Clearing heat and detoxicating, wind-heat dissipating.Belong to the heat-clearing and detoxifying drug of antipyretic subordinate classification.
Oriental wormwood：【Meridian distribution of property and flavor】Cold nature, it is bitter, pungent.Returns spleen warp, stomach, bladder warp.
【Effect and effect】Clearing away damp-heat, removing jaundice subcutaneous ulcer.Belong to the damp-excreting anti-icteric medicinal of damp-clearing drug subordinate classification.
Rheum officinale：【Meridian distribution of property and flavor】It is cold in nature, bitter.Returns spleen warp, stomach, large intestine channel, Liver Channel, pericardium channel.
【Effect and effect】Purgating heat and bowels, removing pattogenic heat from the blood and toxic material from the body, dispelling stasis of blood and stimulating the menstrual flow.Belong to the cathartic drug of purgatives medicine subordinate classification.
Phoenix-tail fern：【Meridian distribution of property and flavor】It is cold in nature, mildly bitter flavor.Return large intestine channel, the heart channel of Hang-Shaoyin, Liver Channel.
【Effect and effect】Clearing heat and promoting diuresis, cooling blood and hemostasis, subdhing swelling and detoxicating.Belong to the heat-clearing and detoxifying drug of antipyretic subordinate classification.
Lilac daphne：【Meridian distribution of property and flavor】It is warm-natured, it is bitter, pungent.Return lung warp, the spleen channel, kidney channel.
【Effect and effect】Removing water retention by purgation, external application desinsection treats sore.Belong to the drastically purgating water drug of purgatives medicine subordinate classification.
Said medicine is made into method of the invention is：
Above-mentioned potentilla chinensis, leatherleaf mahonia, Cortex hibisus syriacus, lily, honeysuckle, oriental wormwood, rheum officinale, phoenix-tail fern, each medicine of lilac daphne are mixed, will
Mixed each medicine is soaked 20 minutes using 1500ml warm water, is then boiled using slow fire, filter residue is concentrated into afterwards
600ml, takes in two times, once in the morning and once at night, is within 3rd 1 course for the treatment of.
The beneficial effects of the invention are as follows：The present invention is a kind of be used to treating the Chinese medicine preparation of cholecystitis matched somebody with somebody using Chinese medicine system and
Into easy to use, each medicine supplements and complements each other, regulating qi-flowing for relieving pain, there is certain curative effect to cholecystitis, and without obvious toxic-side effects, cures
Rate is high, safe and reliable, short treating period, and curative effect is fast, and effect is good.
Embodiment
Specific embodiment of the invention given below, is further described for the composition to the present invention.
Embodiment 1
The Chinese medicine preparation for being used to treat cholecystitis of the present invention, its raw material is constituted in mass ratio：9 parts of potentilla chinensis；Leatherleaf mahonia
12 parts；3 parts of Cortex hibisus syriacus；6 parts of lily；6 parts of honeysuckle；6 parts of oriental wormwood；9 parts of rheum officinale；15 parts of phoenix-tail fern；1-3 parts of lilac daphne.
Embodiment 2
The Chinese medicine preparation for being used to treat cholecystitis of the present invention, its raw material is constituted in mass ratio：12 parts of potentilla chinensis；Leatherleaf mahonia
15 parts；9 parts of Cortex hibisus syriacus；6 parts of lily；12 parts of honeysuckle；9 parts of oriental wormwood；21 parts of rheum officinale；33 parts of phoenix-tail fern；3 parts of lilac daphne.
Embodiment 3
The Chinese medicine preparation for being used to treat cholecystitis of the present invention, its raw material is constituted in mass ratio：15 parts of potentilla chinensis；Leatherleaf mahonia
18 parts；9 parts of Cortex hibisus syriacus；15 parts of lily；15 parts of honeysuckle；15 parts of oriental wormwood；30 parts of rheum officinale；60 parts of phoenix-tail fern；3 parts of lilac daphne.
Diagnostic criteria
It is effective：Symptom and sign is wholly absent；
Effectively：Symptom and sign mitigates earlier above；
It is invalid：Symptom and sign is preceding without improvement with treatment.
Randomly select 100 cholecystitis and be divided into treatment group and control group progress clinical test, be randomly divided into treatment group
50, control group 50；Situations such as to the age of two groups of patients, the state of an illness, the course of disease, is compared, statistical procedures, and difference is without aobvious
Work property meaning, two groups of cases have comparativity.
Treatment results
Treatment results are shown in Table 1.
1 two groups of comparitive studies of table
| Group | n | It is effective | Effectively | It is invalid | Total effective rate (%) | Serious adverse reaction example |
| Treatment group | 50 | 15 | 32 | 3 | 94% | 0 |
| Control group | 50 | 10 | 20 | 20 | 60% | 0 |
It can be seen that, medicine produced by the present invention can safely and effectively treat cholecystitis, with promotional value.
The present invention is not limited to the above-described embodiments, anyone should learn the present invention enlightenment under make with the present invention
With same or like technical scheme, each fall within protection scope of the present invention.
Claims (3)
1. a kind of be used to treat the Chinese medicine preparation of cholecystitis, it is characterised in that its raw material composition and ratio is：9-15 parts of potentilla chinensis；
12-18 parts of leatherleaf mahonia；3-9 parts of Cortex hibisus syriacus；6-15 parts of lily；6-15 parts of honeysuckle；6-15 parts of oriental wormwood；9-30 parts of rheum officinale；Phoenix tail
It is careless 15-60 parts；1-3 parts of lilac daphne.
2. a kind of Chinese medicine preparation for being used to treat cholecystitis according to claim 1, it is characterized in that：Its raw material composition
In mass ratio：12 parts of potentilla chinensis；15 parts of leatherleaf mahonia；9 parts of Cortex hibisus syriacus；6 parts of lily；12 parts of honeysuckle；9 parts of oriental wormwood；Rheum officinale
21 parts；33 parts of phoenix-tail fern；3 parts of lilac daphne.
3. a kind of Chinese medicine preparation for being used to treat cholecystitis according to claim 1, it is characterized in that：Its raw material composition
In mass ratio：15 parts of potentilla chinensis；18 parts of leatherleaf mahonia；9 parts of Cortex hibisus syriacus；15 parts of lily；15 parts of honeysuckle；15 parts of oriental wormwood；Greatly
It is yellow 30 parts；60 parts of phoenix-tail fern；3 parts of lilac daphne.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710255336.6A CN107050282A (en) | 2017-04-19 | 2017-04-19 | A kind of Chinese medicine preparation for being used to treat cholecystitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710255336.6A CN107050282A (en) | 2017-04-19 | 2017-04-19 | A kind of Chinese medicine preparation for being used to treat cholecystitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107050282A true CN107050282A (en) | 2017-08-18 |
Family
ID=59600375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710255336.6A Pending CN107050282A (en) | 2017-04-19 | 2017-04-19 | A kind of Chinese medicine preparation for being used to treat cholecystitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107050282A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1454640A (en) * | 2003-03-25 | 2003-11-12 | 六枝特区医药站科技实业开发有限公司 | Gallbladder-clearing capsule |
| CN103316174A (en) * | 2013-07-10 | 2013-09-25 | 朱克兰 | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof |
-
2017
- 2017-04-19 CN CN201710255336.6A patent/CN107050282A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1454640A (en) * | 2003-03-25 | 2003-11-12 | 六枝特区医药站科技实业开发有限公司 | Gallbladder-clearing capsule |
| CN103316174A (en) * | 2013-07-10 | 2013-09-25 | 朱克兰 | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 朱江等: "茵陈蒿汤的抗炎镇痛作用", 《武警医学院学报》 * |
| 王吉耀等: "自拟龙凤散治疗胆囊炎26例疗效观察", 《深圳中西医结合杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1899500A (en) | Acne clearing decoction | |
| CN104825680A (en) | Traditional Chinese medicine ointment for treating burn injury | |
| CN107050282A (en) | A kind of Chinese medicine preparation for being used to treat cholecystitis | |
| CN106344754A (en) | Unguent for treating haemorrhoids | |
| CN110339231B (en) | Traditional Chinese medicine composition for treating allergic dermatitis and preparation method thereof | |
| CN102716458A (en) | Health-care medicinal liquor for ameliorating rheumatic arthritis and method for preparing same | |
| CN107019764A (en) | A kind of medicine for treating pneumonia | |
| CN104873598A (en) | Chinese medicinal composition for treating infantile hand-foot-mouth disease | |
| CN104958613B (en) | Chinese medicine composition of malicious decomposed type decubital ulcer and preparation method thereof is accumulate in a kind for the treatment of | |
| CN104189777A (en) | Traditional Chinese medicine preparation for treating mastitis | |
| CN106310104A (en) | Traditional Chinese medicine for treating rheumatism | |
| CN111450196B (en) | Traditional Chinese medicine composition with acne removing function and preparation method and application thereof | |
| CN106334122A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN106362105A (en) | Traditional Chinese medicine composition capable of treating anal fissure | |
| CN105770637A (en) | Pharmaceutical composition for treating gynecological inflammations | |
| CN106974999A (en) | A kind of Chinese medicine composition for treating canker sore | |
| CN107029088A (en) | It is a kind of to improve dull-witted blood-nourishing and refresh oneself capsule | |
| CN106955316A (en) | A kind of Chinese medicine of Neurology treatment insomnia | |
| CN106421285A (en) | Wound repair dressing | |
| CN109820988A (en) | It is a kind of to treat the swollen object Chinese medicine composition of vocal cords and preparation method | |
| CN105663504A (en) | Traditional Chinese medicine ointment for treating incision or trauma infection | |
| CN105055676A (en) | Humifuse euphorbia herb oral solution | |
| CN111557980A (en) | Composition and preparation method thereof | |
| CN115554351A (en) | Ointment for treating intervertebral disc protrusion and preparation method thereof | |
| CN104491104A (en) | Traditional Chinese medicine composition for treating bedsore in clinical care |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170818 |
|
| RJ01 | Rejection of invention patent application after publication |